查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362961

融合切片檢查市場規模、佔有率和趨勢分析報告：切片檢查切片檢查途徑、最終用途、地區和細分趨勢，2023-2030

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

融合切片檢查市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到2030年，全球融合切片檢查市場規模預計將達到 11.156 億美元，預測期內年複合成長率為 8.6%。

前列腺癌盛行率不斷上升，對標靶切片檢查的需求不斷增加，以及多波長 MRI 在前列腺癌治療中的使用不斷增加，預計將在預測期內推動市場發展。此外，人們對常規治療性介入價值的認知不斷提高以及新興的償付政策等因素預計將推動對融合切片檢查市場的需求。

與 TRUS切片檢查、PSA 檢測和直腸指檢等其他傳統技術相比，標靶融合切片檢查由於其在描繪前列腺病變方面具有更高的敏感性和特異性，預計將有助於市場成長。融合切片檢查系統在診斷進行性腫瘤方面的可靠性和可重複性有望使其成為前列腺切片檢查的標準工具。越來越多的放射科醫生獲得前列腺 MRI 解讀方面的專業知識，加上 PI-RADS 和 Gleason 評分等標準影像分類系統的引進，導致了靶向 MR/超音波融合切片檢查系統的利用率提高。

政府在資助前列腺癌相關研究、普及意識和實施大規模篩檢計畫方面的措施預計將在市場成長中發揮關鍵作用。市場參與企業採取的成長策略包括合作夥伴關係、產品發布、參加貿易展覽和會議以及收購，以推動和維持這個競爭激烈的領域的成長。

融合切片檢查市場報告亮點

  • 作為前列腺融合切片檢查的黃金標準和常用方法，經直腸部門在2022年佔據最大的市場佔有率。
  • 由於其安全性、診斷效率和進入腹側前列腺區域的能力，經直腸區隔預計在預測期內將以最快的速度成長。
  • 由於教學醫院MR/ 美國標靶融合切片檢查系統採購率增加等因素，醫院部門在2022年佔據了最大的收益佔有率。
  • 預計診斷中心部門在預測期內將以顯著的速度擴張。減少等待時間、提高成本效率和開發償付模式是推動該領域成長的因素。
  • 北美在2022年佔據最大的市場佔有率，預計在預測期內將保持其主導地位。
  • 預計亞太地區在預測期內的年複合成長率為 9.9%。這是由於泌尿系統對 MRI/ 美國標靶融合切片檢查系統的敏感性和特異性的認知不斷提高，特別是在日本、澳洲和中國等國家。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 融合切片檢查市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 融合切片檢查市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略
    • COVID-19感染疾病的影響分析

第4章 融合切片檢查市場：切片檢查路徑估計及趨勢分析

  • 定義和範圍
  • 2022年及2030年切片檢查途徑市場佔有率
  • 細分儀表板
  • 按切片檢查途徑分類的全球融合切片檢查市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第5章 融合切片檢查市場：最終用途估計和趨勢分析

  • 定義和範圍
  • 2022年及2030年最終用途市場佔有率
  • 細分儀表板
  • 依最終用途分類的融合切片檢查市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第6章 融合切片檢查市場：區域估計和趨勢分析

  • 2022年及2030年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場概述
  • 2022年區域市場佔有率和主要企業
  • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
  • 2022年至2030年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
    • 市場領導者
    • 新興玩家
  • 供應商形勢
  • 上市公司
    • 公司市場分析（收益、地理分佈、產品系列、主要服務業、主要聯盟）
    • 企業市場佔有率/地區排名
    • 競爭儀表板分析
  • 私人公司
    • 主要新興企業/技術顛覆者/創新者名單
    • 資金籌措
    • 區域網路圖
    • 公司市場分析（地理位置、產品系列、主要聯盟、產業經驗）
    • 供應商排名
    • 主要企業簡介
    • Eigen
    • Koninklijke Philips NV
    • Hitachi, Ltd.
    • MedCom
    • ESAOTE SPA
    • KOELIS
    • Focal Healthcare
    • GeoScan Medical
    • UC-Care Medical Systems Ltd.
Product Code: GVR-4-68038-844-2

Fusion Biopsy Market Growth & Trends:

The global fusion biopsy market size is expected to reach USD 1,115.6 million by 2030, advancing at a CAGR of 8.6% during the forecast period, according to a new report by Grand View Research, Inc.. The increasing prevalence of prostate cancer, growing demand for targeted biopsy, and the rising utilization rate of multipara metric MRI in prostate cancer care are factors expected to drive the market during the forecast period. Moreover, factors such as rising awareness of the value of routine therapeutic interventions and emerging reimbursement policies are projected to drive demand in the market for fusion biopsy.

The high sensitivity and specificity of targeted fusion biopsy in delineating prostate lesions compared to other traditional technologies such as TRUS biopsy, PSA test, or Digital Rectal Examination is expected to contribute to the market growth. The reliability & reproducibility of the fusion biopsy system in the diagnosis of aggressive tumors is expected to make it a standard tool in prostate biopsy. An increasing number of radiologists gaining expertise in interpreting prostate MRI, coupled with the implementation of standard image grading systems such as PI-RADS and Gleason score, has increased the utilization rate of targeted MR/Ultrasound fusion biopsy systems.

The increasing number of government initiatives in terms of funding research, spreading awareness, and conducting mass screening programs related to prostate cancer are expected to play a crucial in the growth of the market. Some of the growth strategies adopted by market players include partnerships, product launches, participation in trade events and conferences, and acquisitions to drive and sustain growth in this highly competitive space.

Fusion Biopsy Market Report Highlights:

  • The transrectal segment held the largest market share in 2022, as it is the gold standard and commonly used method of prostate fusion biopsy
  • The transperineal segment is expected to grow at the fastest rate during the forecast period owing to the safety, diagnostic efficiency, and ability to access ventral prostate areas
  • The hospital segment accounted for the largest revenue share in 2022, owing to factors such as the increasing procurement rate of MR/US targeted fusion biopsy systems in teaching hospitals
  • The diagnostics centers segment is expected to expand at a significant rate over the forecast period. Shorter wait times, cost efficiency, and developing reimbursement paradigm are the factors expected to drive the growth of this segment
  • North America held the largest market share in 2022 and is anticipated to maintain its dominance over the forecast period
  • Asia Pacific is anticipated to witness a CAGR of 9.9% during the forecast period, owing to factors such as the growing awareness about the sensitivity and specificity of MRI/US targeted fusion biopsy systems among urologists, especially in countries such as Japan, Australia, and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Biopsy route
    • 1.1.2. End-use
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Biopsy route outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Fusion Biopsy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of prostate cancer
      • 3.4.1.2. Technological advancements in fusion imaging modalities
      • 3.4.1.3. Increasing funds and investments by public and private sector
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of fusion biopsy system
      • 3.4.2.2. Liquid biopsy system
  • 3.5. Fusion Biopsy Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's Five Forces
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies
    • 3.5.5. COVID-19 Impact Analysis

Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Transrectal
    • 4.1.2. Transperineal
  • 4.2. Biopsy Route Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Transrectal
      • 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 4.5.2. Transperineal
      • 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Diagnostic centers
    • 5.1.3. Ambulatory care centers
  • 5.2. End-use Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Fusion Biopsy Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Diagnostic centers
      • 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. Ambulatory care centers
      • 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2022
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts and Trend Analysis, 2022 to 2030:
  • 6.7. North America
    • 6.7.1. U.S.
      • 6.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Canada
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.8. Europe
    • 6.8.1. UK
      • 6.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.2. Germany
      • 6.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.3. France
      • 6.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.4. Italy
      • 6.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.5. Spain
      • 6.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.6. Denmark
      • 6.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.7. Sweden
      • 6.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.8. Norway
      • 6.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Japan
      • 6.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.2. China
      • 6.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.3. India
      • 6.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.4. South Korea
      • 6.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.5. Thailand
      • 6.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.6. Australia
      • 6.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.10. Latin America
    • 6.10.1. Brazil
      • 6.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.10.2. Mexico
      • 6.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.10.3. Argentina
      • 6.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.11. MEA
    • 6.11.1. South Africa
      • 6.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.2. Saudi Arabia
      • 6.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.3. UAE
      • 6.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.4. Kuwait
      • 6.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competitive Categorization
    • 7.2.1. Innovators
    • 7.2.2. Market leaders
    • 7.2.3. Emerging players
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2019
  • 7.4. Public Companies
    • 7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 7.4.2. Company market share/ranking, by region
    • 7.4.3. Competitive dashboard analysis
      • 7.4.3.1. Market differentiators
      • 7.4.3.2. Synergy analysis: major deals and strategic alliances
  • 7.5. Private Companies
    • 7.5.1. List of key emerging companies/technology disruptors/innovators
    • 7.5.2. Funding outlook
    • 7.5.3. Regional network map
    • 7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 7.5.5. Supplier ranking
    • 7.5.6. Key company profiled
    • 7.5.7. Eigen
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Koninklijke Philips N.V.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Hitachi, Ltd.
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. MedCom
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. ESAOTE SPA
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Product benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. KOELIS
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Product benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. Focal Healthcare
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Product benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. GeoScan Medical
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Product benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. UC-Care Medical Systems Ltd.
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Product benchmarking
      • 7.5.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 4 North America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 6 U.S. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 8 Canada fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 11 Europe fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.K. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 13 U.K. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 15 Germany fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Italy fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 17 Italy fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 France fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 19 France fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 21 Spain fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 23 Denmark fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 25 Sweden fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 27 Norway fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Japan fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 32 Japan fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 India fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 34 India fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 36 China fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Thailand fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 38 Thailand fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 40 South Korea fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 42 Australia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 45 Latin America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 47 Brazil fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 49 Mexico fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 51 Argentina fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 54 MEA fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 56 South Africa fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 60 UAE fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 62 Kuwait fusion biopsy market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Data triangulation techniques
  • Fig. 3. Primary research pattern
  • Fig. 4. Primary interviews in North America
  • Fig. 5. Primary interviews in Europe
  • Fig. 6. Primary interviews in APAC
  • Fig. 7. Primary interviews in Latin America
  • Fig. 8. Primary interviews in MEA
  • Fig. 9. Market research approaches
  • Fig. 10. Value-chain-based sizing & forecasting
  • Fig. 11. QFD modeling for market share assessment
  • Fig. 12. Market formulation & validation
  • Fig. 13. Fusion biopsy market: market outlook
  • Fig. 14. Fusion biopsy market competitive insights
  • Fig. 15. Parent market outlook
  • Fig. 16. Related/ancillary market outlook
  • Fig. 17. Penetration and growth prospect mapping
  • Fig. 18. Industry value chain analysis
  • Fig. 19. Fusion biopsy market driver impact
  • Fig. 20. Fusion biopsy market restraint impact
  • Fig. 21. Fusion biopsy market strategic initiatives analysis
  • Fig. 22. Fusion biopsy market: biopsy route movement analysis
  • Fig. 23. Fusion biopsy market: biopsy route outlook and key takeaways
  • Fig. 24. Transrectal market estimates and forecast, 2018 - 2030
  • Fig. 25. Transperineal market estimates and forecast, 2018 - 2030
  • Fig. 26. Fusion biopsy market: end-use movement analysis
  • Fig. 27. Fusion biopsy market: end-use outlook and key takeaways
  • Fig. 28. Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 29. Diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 30. Ambulatory care centers market estimates and forecast, 2018 - 2030
  • Fig. 31. Fusion biopsy market: regional movement analysis
  • Fig. 32. Fusion biopsy market: regional outlook and key takeaways
  • Fig. 33. Fusion biopsy market share and leading players
  • Fig. 34. North America market share and leading players
  • Fig. 35. Europe market share and leading players
  • Fig. 36. Asia Pacific market share and leading players
  • Fig. 37. Latin America market share and leading players
  • Fig. 38. Middle East & Africa market share and leading players
  • Fig. 39. North America: SWOT
  • Fig. 40. Europe SWOT
  • Fig. 41. Asia Pacific SWOT
  • Fig. 42. Latin America SWOT
  • Fig. 43. MEA SWOT
  • Fig. 44. North America, by country
  • Fig. 45. North America
  • Fig. 46. North America market estimates and forecast, 2018 - 2030
  • Fig. 47. U.S.
  • Fig. 48. U.S. market estimates and forecast, 2018 - 2030
  • Fig. 49. Canada
  • Fig. 50. Canada market estimates and forecast, 2018 - 2030
  • Fig. 51. Europe
  • Fig. 52. Europe market estimates and forecast, 2018 - 2030
  • Fig. 53. UK
  • Fig. 54. UK market estimates and forecast, 2018 - 2030
  • Fig. 55. Germany
  • Fig. 56. Germany market estimates and forecast, 2018 - 2030
  • Fig. 57. France
  • Fig. 58. France market estimates and forecast, 2018 - 2030
  • Fig. 59. Italy
  • Fig. 60. Italy market estimates and forecast, 2018 - 2030
  • Fig. 61. Spain
  • Fig. 62. Spain market estimates and forecast, 2018 - 2030
  • Fig. 63. Denmark
  • Fig. 64. Denmark market estimates and forecast, 2018 - 2030
  • Fig. 65. Sweden
  • Fig. 66. Sweden market estimates and forecast, 2018 - 2030
  • Fig. 67. Norway
  • Fig. 68. Norway market estimates and forecast, 2018 - 2030
  • Fig. 69. Asia Pacific
  • Fig. 70. Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 71. China
  • Fig. 72. China market estimates and forecast, 2018 - 2030
  • Fig. 73. Japan
  • Fig. 74. Japan market estimates and forecast, 2018 - 2030
  • Fig. 75. India
  • Fig. 76. India market estimates and forecast, 2018 - 2030
  • Fig. 77. Thailand
  • Fig. 78. Thailand market estimates and forecast, 2018 - 2030
  • Fig. 79. South Korea
  • Fig. 80. South Korea market estimates and forecast, 2018 - 2030
  • Fig. 81. Australia
  • Fig. 82. Australia market estimates and forecast, 2018 - 2030
  • Fig. 83. Latin America
  • Fig. 84. Latin America market estimates and forecast, 2018 - 2030
  • Fig. 85. Brazil
  • Fig. 86. Brazil market estimates and forecast, 2018 - 2030
  • Fig. 87. Mexico
  • Fig. 88. Mexico market estimates and forecast, 2018 - 2030
  • Fig. 89. Argentina
  • Fig. 90. Argentina market estimates and forecast, 2018 - 2030
  • Fig. 91. Middle East and Africa
  • Fig. 92. Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 93. South Africa
  • Fig. 94. South Africa market estimates and forecast, 2018 - 2030
  • Fig. 95. Saudi Arabia
  • Fig. 96. Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 97. UAE
  • Fig. 98. UAE market estimates and forecast, 2018 - 2030
  • Fig. 99. Kuwait
  • Fig. 100. Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 101. Participant categorization - fusion biopsy market
  • Fig. 102. Market share of key market players - fusion biopsy market